REVELATION BIOSCIENCES INC (REVB) Stock News
NASDAQ:REVB - Nasdaq - US76135L6065 - Common Stock - Currency: USD
REVB Latest News, Press Relases and Analysis
Which stocks have an unusual volume on Wednesday?
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Wondering what's happening in today's after-hours session?
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Unusual volume stocks in Tuesday's session
In today's session, these stocks are experiencing unusual volume.
Tuesday's session: gap up and gap down stocks
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Tuesday's pre-market session: top gainers and losers
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
S&P lowers outlook on Volvo Cars rating citing US tariffs, competition in China
STOCKHOLM (Reuters) -S&P on Friday lowered the outlook for its BB+ credit rating on Volvo Cars to "negative" from "stable", saying U.S. tariffs and tougher competition in China were hurting the company's growth prospects. The Sweden-based automaker, which is majority-owned by China's Geely, last month withdrew its earnings guidance and announced cost cuts, which will include laying off some 3,000 mostly white-collar workers amid a slowdown in demand. "The negative outlook on Volvo Cars reflects its large exposure to U.S. import tariffs and the increasing marginalisation in the Chinese market," S&P said in a statement.
Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering
Revelation Biosciences, Inc. (NASDAQ:REVB), a clinical-stage life sciences company dedicated to rebalancing inflammation for improved health outcomes, has successfully closed a public offering, raising approximately $4 million in gross proceeds. The offering included 3,640,000 shares of common stock (or equivalents) and warrants to purchase up to 14,560,000 shares, all priced at $1.10 per share and […]
Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering
Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025
Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients
Why Revelation Biosciences Inc. (REVB) Went Down On Thursday?
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where Revelation Biosciences Inc. (NASDAQ:REVB) stands against other stocks that fall behind amid market optimism. Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that […]
Mentions: TSLA
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients
